1[1]Jacoby GA,Mederiros AA. More extended-spectrum β-lactamases[J]. Antimicrob Agents Chemother,1991, 35(9):1697-1704.
2[4]Sanders CC,Barry AL, Washington JA, et al. Detection of extended-spectrum β-lactamases-producing members of the family Enterobacteriaceae with the VITEK ESBLs test [J]. J Clin Microbiol, 1996,34(12): 2997-3001.
3[5]Livermore DM. β-Lactamases in laboratory and clinical resistance [J]. J Clin Microbiol Rev, 1995, 8(3): 557-584.
4[6]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement [S]. NCCLS, 1999.19: 36-75.
5[9]Rasmussen BA, Bush K. Carbapenem-hydrolyzing β-lactamases [J]. Antimicrob Agents Chemother, 1997, 41(2): 223-232.
6[10]Coudron PE, Molaand ES, Thomoson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center[J]. J Clin Microbiol, 2000, 38(5):1791-1796.
7[11]Jacoby GA, Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli [J]. J Clin Microbiol, 1996, 34(4): 908-911.
